We recommend you to use PAREXEL International fundamental analysis to find out if markets are now mispricing the company. In other words this interface allows you to confirm available drivers of PAREXEL International as well as the relationship between them. We found thirty-six available financial ratios for PAREXEL International which can be compared to its competitors. To make sure the equity is not overpriced, please check all PAREXEL International fundamentals including its EBITDA and the relationship between Current Ratio and Current Asset . As PAREXEL International appears to be a penny stock we also advise to check out its Number of Shares Shorted numbers.
PAREXEL International Company Summary
PAREXEL International competes with Vertex Pharmaceuticals, Dr Reddys, Zoetis, Perrigo Company, and Regeneron Pharmaceuticals. PAREXEL International Corporationration, a biopharmaceutical services company, offer clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology solutions and services for pharmaceutical, biotechnology, and medical device industries worldwide.
PAREXEL International Total Asset vs Shares Owned by Insiders
PAREXEL International Corp is considered to be number one stock in total asset category among related companies. It is regarded third in shares owned by insiders category among related companies . The ratio of Total Asset to Shares Owned by Insiders for PAREXEL International Corp is about 1,018,100,000
|Shares Owned by Insiders ( % )|
PAREXEL International Market Fundamentals